Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related PFE
The Market In 5 Minutes: No Interest Rate Hike...Yet
Can You Guess This Chart?
Amgen, Biogen Pitted In M&A Scenario; Adamas, Acadia Draw Interest (Investor's Business Daily)
Related LNKD
Microsoft Showing Shareholders A Lot Of Love With Dividend Increases, Buybacks
Analysts See Facebook, Google Able To Withstand Ad Dollar Competition From Snapchat; Twitter Not So Much
Facebook, Fraudbook?; Twitter Buyout; Tesla's Solar Roof, Lawsuit Against Michigan -- Eye On Tech (Seeking Alpha)

Analysts at Citigroup initiated coverage on shares of Pfizer (NYSE: PFE) with a “buy” rating. Pfizer's shares closed at $24.85 yesterday. Pfizer's trailing-twelve-month operating margin is 31.27%.

Wedbush initiated coverage on shares of LinkedIn (NYSE: LNKD) with a “neutral” rating. LinkedIn's stock closed at $107.11 yesterday. LinkedIn's trailing-twelve-month ROE is 2.76%.

Wells Fargo initiated coverage on shares of Hess (NYSE: HES) with a “market perform” rating. Hess' shares closed at $50.50 yesterday. Hess had $528.00 million in total cash for the recent quarter.

Analysts at Mizuho initiated coverage on shares of Salix Pharmaceuticals (NASDAQ: SLXP) with a “buy” rating. Salix's shares closed at $41.26 yesterday. Salix's PEG ratio is 0.62.

Latest Ratings for PFE

DateFirmActionFromTo
Sep 2016JefferiesMaintainsBuy
Aug 2016JefferiesMaintainsBuy
Jul 2016JefferiesMaintainsBuy

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (HES + LNKD)

View Comments and Join the Discussion!